Literature DB >> 14616932

Association between ACE inhibitors use and headache caused by nitrates among hypertensive patients: results from the Italian group of pharmacoepidemiology in the elderly (GIFA).

G Onder1, M Pahor, G Gambassi, A Federici, A Savo, P Carbonin, R Bernabei.   

Abstract

Treatment with ACE inhibitors has shown to be effective in the prophylaxis of migraine attacks. The aim of this study was to explore whether among hospitalized hypertensive patients use of ACE inhibitors may reduce the risk of headache caused by nitrates. To this end, we used the GIFA database, that includes patients admitted to academic medical centres throughout Italy. We studied 1537 patients (mean age 75 +/- 10 years) receiving treatment with nitrates during a hospital stay and diagnosed with hypertension. Headaches that had a probable or definite causal relation with nitrates use based on the Naranjo algorithm were considered for this analysis. Of the total enrolled sample, 762 patients (50%) used ACE inhibitors during hospital stay. Headache caused by nitrates was recorded in 12/762 (1.6%) ACE inhibitor users and in 24/775 (3.2%) other participants (P = 0.049). After adjusting for potential confounders, ACE inhibitors use was associated with a significantly lower risk of headache (OR 0.43; 95% Confidence Intervals: 0.20-0.90). This result was confirmed if ACE inhibitors use was compared with use of other antihypertensive agents (OR 0.44; 95% CI 0.20-0.95). In conclusion, this study suggests that among hypertensive subjects use of ACE inhibitors is associated with a reduced risk of headache caused by nitrates.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14616932     DOI: 10.1046/j.1468-2982.2003.00627.x

Source DB:  PubMed          Journal:  Cephalalgia        ISSN: 0333-1024            Impact factor:   6.292


  7 in total

1.  ACE and ARB Agents in the Prophylactic Therapy of Migraine-How Effective Are They?

Authors:  Rashmi B Halker; Amaal J Starling; Bert B Vargas; Todd J Schwedt
Journal:  Curr Treat Options Neurol       Date:  2016-04       Impact factor: 3.598

Review 2.  Role of angiotensin modulation in primary headaches.

Authors:  Erling Tronvik; Lars Jacob Stovner
Journal:  Curr Pain Headache Rep       Date:  2014-05

3.  An evidence-based systematic review of the off-label uses of lisinopril.

Authors:  Seyyed-Reza Sadat-Ebrahimi; Neda Parnianfard; Nafiseh Vahed; Hossein Babaei; Morteza Ghojazadeh; Sydney Tang; Amir Azarpazhooh
Journal:  Br J Clin Pharmacol       Date:  2018-09-11       Impact factor: 4.335

Review 4.  Potentially inappropriate medication in elderly hospitalized patients.

Authors:  Andrea Corsonello; Luigi Pranno; Sabrina Garasto; Paolo Fabietti; Silvia Bustacchini; Fabrizia Lattanzio
Journal:  Drugs Aging       Date:  2009-12       Impact factor: 3.923

5.  Efficacy of Enalapril in Migraine Prophylaxis: A Randomized, Double-blind, Placebo-controlled Trial.

Authors:  Seyed Ali Sonbolestan; Kiyan Heshmat; Shaghayegh Haghjooy Javanmard; Mohammad Saadatnia
Journal:  Int J Prev Med       Date:  2013-01

6.  Elevated blood pressure and analgesic overuse in chronic daily headache: an outpatient clinic-based study from China.

Authors:  Qingqing Huang; Wangwen Li; Nan Li; Jing Wang; Ge Tan; Lixue Chen; Guangcheng Qin; Xiping Liang; Jiying Zhou
Journal:  J Headache Pain       Date:  2013-06-17       Impact factor: 7.277

Review 7.  Angiotensin-converting enzyme inhibitors side effects--physiologic and non-physiologic considerations.

Authors:  Domenic A Sica
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-07       Impact factor: 3.738

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.